Efficacy and Safety of Anti-SARS-CoV-2 Antiviral Agents and Monoclonal Antibodies in Patients with SLE: A Case-Control Study

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-related disease (COVID-19) has spread pandemically with high rates of morbidity and mortality. COVID-19 has also posed unprecedented challenges in terms of rapid development of pharmacological countermeasures to prevent or contrast SARS-Co...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Giuseppe A. Ramirez, Maria Gerosa, Chiara Bellocchi, Daniel Arroyo-Sánchez, Chiara Asperti, Lorenza M. Argolini, Gabriele Gallina, Martina Cornalba, Isabella Scotti, Ilaria Suardi, Luca Moroni, Lorenzo Beretta, Enrica P. Bozzolo, Roberto Caporali, Lorenzo Dagna
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	MDPI AG 2023-08-01
Serie:	Biomolecules
Soggetti:	systemic lupus erythematosus COVID-19 SARS-CoV-2 antivirals monoclonal antibodies
Accesso online:	https://www.mdpi.com/2218-273X/13/9/1273
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!